Tetrahydromagnolol targets TRIM38 to mediate PANoptosis in cancer cells and has the potential for synergistic cancer therapy
Xiaoqing Gu, Lin Li, Ting Duan, Lijun Jin, Qinsong Sheng, Quan Gao, Mengting Chen, Xinbing Sui · 2025
Read Tetrahydromagnolol targets TRIM38 to mediate PANoptosis in cancer cells and has the potential for synergistic cancer therapy by Xiaoqing Gu, Lin Li, Ting Duan, Lijun Jin, Qinsong Sheng, Quan Gao, Mengting Chen, Xinbing Sui (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12781742.txt.
Description
Xiaoqing Gu and seven co-authors test a magnolia bark compound against cancer cells and find the switch it hits, in a 2025 journal article. The compound, called THM, had an unclear record as a cancer fighter. The team checked it on bowel and lung cancer, in dishes and in mice.
The compound curbed cell growth and drove a mixed death that blends three known death paths at once. Gene reads and binding tests pinned its target to a protein called TRIM38. Stress rose in cell power plants and protein folds as the compound worked. In mice the compound slowed tumors, and it teamed well with standard drugs for bowel cancer. The authors see a fresh lead for paired therapy.
Catalog record
| CREATOR | Xiaoqing Gu, Lin Li, Ting Duan, Lijun Jin, Qinsong Sheng, Quan Gao, Mengting Chen, Xinbing Sui |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 74 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |